Sana Biotechnology Inc.

1.60
-0.11 (-6.43%)
At close: Mar 31, 2025, 10:44 AM

Sana Biotechnology Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 127.57M 133.52M 176.76M 253.03M 412M 80.03M 30.63M
Short-Term Investments 24.93M 71.68M 247.2M 297.97M 253.46M 58.95M n/a
Long-Term Investments n/a n/a 10.05M 195.88M 33.73M 1.78M 816K
Other Long-Term Assets 5.12M 6.37M 9.01M 13.82M 2.33M 2.3M 336K
Receivables n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 8.31M 8.32M 20.47M 14.21M 12.41M 10.56M 1.97M
Total Current Assets 160.81M 213.51M 444.44M 558.1M 384.47M 144.26M 32.6M
Property-Plant & Equipment 135.27M 145.59M 159.4M 161.78M 109.94M 69.31M 585K
Goodwill & Intangibles 199.82M 199.82M 199.82M 199.82M 199.82M 199.82M n/a
Total Long-Term Assets 340.21M 351.78M 378.28M 571.31M 345.83M 271.44M 1.74M
Total Assets 501.02M 565.3M 822.72M 1.13B 730.3M 415.7M 34.33M
Account Payables 5.21M 4.11M 2.86M 2.22M 2.25M n/a 289K
Deferred Revenue n/a n/a n/a 31.48M n/a n/a n/a
Short-Term Debt 12.53M 13.2M 24.79M 18.32M 7.42M 1.34M n/a
Other Current Liabilities 27.69M 47.18M 83.86M 78.7M 21.77M 18.49M 1.5M
Total Current Liabilities 45.43M 64.49M 111.5M 99.23M 31.45M 19.83M 1.78M
Long-Term Debt 81.66M 90.9M 191.72M 203.57M 136.39M 46.36M n/a
Other Long-Term Liabilities 123.42M 122.41M 20.18M 98.1M 983.63M 492.05M 45.74M
Total Long-Term Liabilities 205.08M 213.31M 211.9M 301.67M 1.12B 538.41M 45.74M
Total Liabilities 250.52M 277.79M 323.4M 400.9M 1.15B 558.24M 47.52M
Total Debt 94.2M 104.1M 108.25M 110.94M 71.91M 48.21M n/a
Common Stock 22K 20K 19K 18K 2K 1K 1K
Retained Earnings -1.6B -1.34B -1.05B -785.36M -429.43M -144.13M -13.25M
Comprehensive Income 14K -60K -4.33M -1.37M 30K 26K -45.72M
Shareholders Equity 250.5M 287.51M 499.31M 728.5M -421.18M -142.54M -13.19M
Total Investments 24.93M 71.68M 257.25M 493.85M 287.19M 58.95M 816K